Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kögler, H Fraser, S McCune… - Cardiovascular …, 2003 - academic.oup.com
Objective: Xanthine oxidase (XO) inhibitors enhance myofilament Ca2+ responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …
被引用次数：61 相关文章

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kogler, H Fraser, S McCune, R Altschuld… - Cardiovascular …, 2003 - elibrary.ru
Objective: Xanthine oxidase (XO) inhibitors enhance myofilament Ca2+ responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kögler, H Fraser, S McCune, R Altschuld… - Cardiovascular …, 2003 - infona.pl
Objective: Xanthine oxidase (XO) inhibitors enhance myofilament Ca 2+ responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kogler, H Fraser, S McCune, R Altschuld… - 2003 - publications.goettingen-research …
Objective: Xanthine oxidase (XO) inhibitors enhance myofilament Ca2+ responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

[引用][C] Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H KOGLER - Cardiovascular Research, 2003 - cir.nii.ac.jp
Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor
oxypurinol in failing rat myocardium | CiNii Research CiNii 国立情報学研究所 学術情報 …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kögler, H Fraser, S McCune… - Cardiovascular …, 2003 - pubmed.ncbi.nlm.nih.gov
Objective Xanthine oxidase (XO) inhibitors enhance myofilament Ca (2+) responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kögler, H Fraser, S McCune… - Cardiovascular …, 2003 - pure.johnshopkins.edu
Objective: Xanthine oxidase (XO) inhibitors enhance myofilament Ca 2+ responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.

H Kögler, H Fraser, S McCune, R Altschuld… - Cardiovascular …, 2003 - europepmc.org
Objective Xanthine oxidase (XO) inhibitors enhance myofilament Ca (2+) responsiveness of
normal rat myocardium. We examined whether this inotropic action is preserved or …

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H Kögler, H Fraser, S McCune… - Cardiovascular …, 2003 - search.ebscohost.com
Abstract < B> Objective: </B> Xanthine oxidase (XO) inhibitors enhance
myofilament Ca< sup> 2+</sup> responsiveness of normal rat myocardium. We examined …

[引用][C] Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

H KÖGLER, H FRASER, S MCCUNE… - Cardiovascular …, 2003 - pascal-francis.inist.fr
Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor
oxypurinol in failing rat myocardium CNRS Inist Pascal-Francis CNRS Pascal and Francis …